How I treat cytopenias after CAR T-cell therapy

Increasing use of chimeric antigen receptor T-cell therapy (CAR-T) has unveiled diverse toxicities warranting specific recognition and management. Cytopenias occurring after CAR-T infusion invariably manifest early (<30 days), commonly are prolonged (30-90 days), and sometimes persist or occur la...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Tania, Olson, Timothy S., Locke, Frederick L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Emergent Car T-Cell Toxicities
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646792/
https://www.ncbi.nlm.nih.gov/pubmed/36800563
http://dx.doi.org/10.1182/blood.2022017415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646792/
https://www.ncbi.nlm.nih.gov/pubmed/36800563
http://dx.doi.org/10.1182/blood.2022017415

Ejemplares similares